On-Demand Vonoprazan for Non-Erosive Reflux Disease Symptoms: A New Option
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Christopher Velez, MD discuss “Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease,” by Fass R, Vaezi M, Sharma P, et al. Aliment Pharmacol Ther. 2023 Nov;58(10):1016-1027.
Information
- Show
- Published20 November 2024 at 16:00 UTC
- Length15 min
- RatingClean